維德思投資 VRTS 深 滬
已收盤 02-06 16:00:00 美东时间
140.29
-10.670
-7.07%
華盛通- 最 高149.20
- 今 開147.00
- 成交量 11.33万股
- 最 低 140.23
- 昨 收 150.96
- 總市值 9.48亿
- 52周最高 208.01
- 市盈率 靜 8.31
- 換手率 1.68%
- 52周最低 132.88
- 委 比 0.00%
- 總股本 675.44万
- 歷史最高 304.80
- 量 比 0.71
- 振 幅 5.94%
- 歷史最低 0.29
- 每 手 1
- 風險率 15.23%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多电话会总结 ｜ Virtus(VRTS)2025财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Virtus业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** 投资管理费用（经调整）为1.689亿美元，环比下降4%，主要由于平均管理资产规模下降和平均费率略微降低。平均费率为40.6个基点，较上季度的41.1个基点有所下降。 **利润率表现：** 经调整营业利润率为32.4%，较上季度的33%下降60个基点，主要受平均资产管理规模减少影响。 **净利润：** 经调整每股摊薄净收益为6.50美元，较上季度的6.69美元下降3%。经调整营业收入为6,110万美元，较第三季度的6,500万美元有所下降。 **现金流和资本
今天 12:01
Zoom, Kinsale Capital, Palantir And A Health Care Stock On CNBC's 'Final Trades'
Bryn Talkington, managing partner of Requisite Capital Management, said Zoom Communications has high free cash flow.
02-06 21:26
Insights into Virtus Inv Q4 Earnings
Virtus Inv (NYSE:VRTS) released its Q4 earnings on Friday, February 6, 2026 at ...
02-06 20:02
Virtus Inv Q4 Adj. EPS $6.50 Beats $6.45 Estimate, Sales $208.023M Beat $191.930M Estimate
Virtus Inv (NASDAQ:VRTS) reported quarterly earnings of $6.50 per share which beat the analyst consensus estimate of $6.45 by 0.85 percent. This is a 13.33 percent decrease over earnings of $7.50 per share from the same
02-06 20:01
Earnings Scheduled For February 6, 2026
Companies Reporting Before The Bell • Biogen (NASDAQ:BIIB) is estimated to repo...
02-06 19:11
Earnings Outlook For Virtus Inv
Virtus Inv (NASDAQ:VRTS) is set to give its latest quarterly earnings report on...
02-06 00:01
美股大行评级 | 泰瑞达、Lumentum、哈贝尔、Enphase能源、西部数据获多家机构上调目标价；PayPal 、恩智浦、墨式烧烤遭多家机构下调目标价
今日重点评级关注：韦德布什：维持Replimune Group"跑赢大市"评级，目标价从18美元升至19美元；巴克莱：维持CytomX Therapeutics"超配"评级，目标价从8美元升至10美元
02-05 11:28
美股大行评级 | 潜在涨幅213.87%！Wave Life Sciences获Canaccord Genuity升目标价至43美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Wave Life Sciences Ltd."买入"评级，目标价从40美元升至43美元；花旗：维持Palantir Technologies"买入"评级，目标价从235美元升至260美元
02-04 12:15
Morgan Stanley Maintains Underweight on Virtus Inv, Lowers Price Target to $155
Morgan Stanley analyst Michael Cyprys maintains Virtus Inv (NYSE:VRTS) with a Underweight and lowers the price target from $168 to $155.
02-03 23:49
Virtus Investment Partners Inc. to Announce Fourth Quarter Results and Host Investor Call
Virtus Investment Partners Inc. to Announce Fourth Quarter Results and Host Investor Call Virtus Investment Partners, Inc. will announce its fourth quarter 2025 financial results before the market opens on Friday, February 6, 2026. A conference call and webcast with the investment community, hosted
01-26 15:38
